Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
- 1 August 2005
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (9), 669-677
- https://doi.org/10.1016/s1470-2045(05)70255-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung CancerJAMA, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- How to calculate the dose of chemotherapyBritish Journal of Cancer, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMFBritish Journal of Cancer, 1999
- The leucocyte nadir, a predictor of chemotherapy efficacy?British Journal of Cancer, 1999
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerBritish Journal of Cancer, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995